A Neurological Safety Protocol for Practitioners Working at the Intersection of Cognitive Decline and Seizure Risk

Your patients with cognitive decline are presenting with episodic changes – agitation, confusion, staring spells, unexplained falls – and there is no standardized clinical tool to document, classify, or communicate these events. SeizureSafe™ Precision is being developed for clinicians who are done accepting that answer.

The Field Labeled It a Behavior. We Believe It Is Biology.

For decades, dementia care has responded to episodic neurological changes by asking behavioral questions. Is the patient overstimulated? Undertreated for anxiety? Experiencing sundowning? These are not wrong questions — but they are incomplete ones. When the answer to every episodic change is a behavioral intervention, the clinician stops looking at the brain.

Research suggests that up to 40% of individuals with dementia may experience subclinical or overt seizure activity. Most are never identified — not because it is invisible, but because the field has never provided a clinical framework for seeing it. What gets labeled as agitation, behavioral decline, or disease progression may be the brain generating a neurological event that requires a fundamentally different response.

For practitioners working in functional and integrative medicine, this gap is not abstract. It appears in your practice every time a patient’s family describes an episode that does not fit the behavioral model — and there is no standardized protocol to pursue your clinical suspicion with precision.

The Dementia Seizure Spectrum™

A Clinical Framework Built for This Problem

The Dementia Seizure Spectrum™ (DSS) is the clinical framework developed by Seagull Health through extensive research. It organizes the four domains in which seizure-related neurological changes appear in individuals with dementia — domains that standard behavioral assessments were never designed to capture.

For practitioners already using biomarker testing as part of their approach to cognitive decline, the DSS connects directly to the cellular mechanisms you are measuring. NAD+ depletion — well-documented in the aging brain — is associated with impaired neuronal energy metabolism, elevated oxidative stress, and increased excitotoxicity: the precise biological environment in which seizure-related activity is more likely to emerge and more likely to go undetected.

The SeizureSafe Protocol:

Four Steps from Suspicion to Clinical Action

SeizureSafe Precision is a standardized neurological safety protocol — a structured clinical framework that trains your care team and your patients’ families to recognize, classify, respond to, and communicate seizure-related changes with the precision a functional diagnosis requires. It does not replace neurology. It creates the observational infrastructure that makes a neurology referral possible, defensible, and data-supported.

Built for Practitioners Who Are Already Asking the Right Questions

SeizureSafe Precision is the right fit if any of the following describes your practice.

• You are seeing patients with a dementia diagnosis who present with episodic changes that do not respond to behavioral interventions and do not fit a clean behavioral explanation. You suspect neurological involvement and you want a clinical system to pursue that suspicion with precision.
• You are working in functional or integrative medicine and are already using biomarker testing as part of your approach to cognitive decline. You need a protocol that captures what is happening neurologically between appointments and connects your lab findings to your patient’s lived experience.
• You are a neurologist, geriatrician, primary care physician, nurse practitioner, or physician assistant managing a cognitively impaired patient population and you want a standardized observation protocol that your patients’ care circle can implement consistently — generating the clinical data you need to make better decisions at the point of care.

This Protocol Is Being Built With Practitioners, Not Just For Them

SeizureSafe Precision is in active development. We are building the practitioner program in direct collaboration with clinicians who are already working at the intersection of cognitive decline, biomarker optimization, and neurological safety. If that describes your practice, we want to hear from you.

You can also register your interest and receive direct updates on the program launch, founding practitioner pricing, and the clinical evidence base as it develops.